Filtering specifically for breast cancer datasets including the risk of metastasis during the first year following treatment, we found correlations between metastatic malignancy and the expression of positive regulators of Wnt/β-catenin signaling (e.g., TCF4) (Fig. 4D). This evidence concerns the gene TCF4 and breast cancer.